{"search_session":{},"preferences":{"l":"en","queryLanguage":"en"},"patentId":"US_8071091_B2","frontPageModel":{"patentViewModel":{"ref":{"entityRefId":"025-536-265-197-48X","entityRefType":"PATENT"},"entityMetadata":{"linkedIds":{"empty":true},"tags":[],"collections":[{"id":11848,"type":"PATENT","title":"University of Leipzig Patent Portfolio","description":"","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":11627,"tags":[],"user":{"id":91044780,"username":"Cambialens","firstName":"","lastName":"","created":"2015-05-04T00:55:26.000Z","displayName":"Cambialens","preferences":"{\"usage\":\"public\",\"beta\":false}","accountType":"PERSONAL","isOauthOnly":false},"notes":[{"id":8460,"type":"COLLECTION","user":{"id":91044780,"username":"Cambialens","firstName":"","lastName":"","created":"2015-05-04T00:55:26.000Z","displayName":"Cambialens","preferences":"{\"usage\":\"public\",\"beta\":false}","accountType":"PERSONAL","isOauthOnly":false},"text":"
Search Applicants and Owners separately:univ* AND Leipzig. Select more for logical variants. Add to collection. Select all patents in the collection and expand by simple families. Add to collection. Total patents: 1306
Search Applicants and Owners separately:univ* AND Leipzig. Select more for logical variants. Add to collection. Select all patents in the collection and expand by simple families. Add to collection. Total patents: 1306
wherein the administration of DSPAα1 has reduced glutamate mediated neurotoxic effects compared to tissue plasminogen activator (t-PA) such that the DSPAα1 can be administered more than 3 hours after onset of stroke symptoms; and\n
wherein the DSPAα1 is not administered in combination with an anti-inflammatory substance or in combination with an anti-coagulant substance."],"number":1,"annotation":false,"claim":true,"title":false},{"lines":["The method according to claim 1, wherein the DSPAα1 is administered to the human within 6 hours after onset of stroke symptoms."],"number":2,"annotation":false,"claim":true,"title":false},{"lines":["The method according to claim 1, wherein the DSPAα1 is administered to the human within 9 hours after onset of stroke symptoms."],"number":3,"annotation":false,"claim":true,"title":false},{"lines":["The method according to claim 1, wherein the DSPAα1 is administered to the human 6 to 9 hours after onset of stroke symptoms."],"number":4,"annotation":false,"claim":true,"title":false},{"lines":["The method according to claim 1, wherein the DSPAα1 is administered to the human 3 to 9 hours after onset of stroke symptoms."],"number":5,"annotation":false,"claim":true,"title":false},{"lines":["The method according to claim 1, wherein the DSPAα1 is administered to the human 3 to 6 hours after onset of stroke symptoms."],"number":6,"annotation":false,"claim":true,"title":false}]}},"filters":{"npl":[],"notNpl":[],"applicant":[],"notApplicant":[],"inventor":[],"notInventor":[],"owner":[],"notOwner":[],"tags":[],"dates":[],"types":[],"notTypes":[],"j":[],"notJ":[],"fj":[],"notFj":[],"classIpcr":[],"notClassIpcr":[],"classNat":[],"notClassNat":[],"classCpc":[],"notClassCpc":[],"so":[],"notSo":[],"sat":[]},"sequenceFilters":{"s":"SEQIDNO","d":"ASCENDING","p":0,"n":10,"sp":[],"si":[],"len":[],"t":[],"loc":[]}}